Page 2 - Longitudinal Evaluation News Today

A test of protein in the blood gets further support as a biomarker for patients diagnosed with frontotemporal dementia (FTD), a group of brain disorders

By City News Service Apr 1, 2021 LOS ANGELES (CNS) - A single dose of the Pfizer-BioNTech vaccine for people who have already had COVID-19 generates an immunologic response similar to that in people who receive the two-dose recommended sequence, according to a study released today by researchers at Cedars-Sinai. The study suggests that the second dose may not be needed for people who have successfully recovered from a prior coronavirus infection, according to Dr. Susan Cheng, an associate prof...